Page last updated: 2024-09-04

5-hydroxybendazac and Cataract, Membranous

5-hydroxybendazac has been researched along with Cataract, Membranous in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bascal, ZA; Wolff, SP; Woollard, AC1
Harding, JJ; Lewis, BS1

Other Studies

2 other study(ies) available for 5-hydroxybendazac and Cataract, Membranous

ArticleYear
Antioxidant characteristics of some potential anticataract agents. Studies of aspirin, paracetamol, and bendazac provide support for an oxidative component of cataract.
    Free radical biology & medicine, 1990, Volume: 9, Issue:4

    Topics: Acetaminophen; Ampyrone; Antioxidants; Aspirin; Biphenyl Compounds; Cataract; Chelating Agents; Erythrocytes; Free Radicals; Hemin; Humans; Hydrazines; Indazoles; Phenol; Phenols; Picrates

1990
The major metabolite of bendazac inhibits the glycosylation of soluble lens proteins: a possible mechanism for a delay in cataractogenesis.
    Experimental eye research, 1988, Volume: 47, Issue:2

    Topics: Animals; Cataract; Cattle; Crystallins; Galactose; Glucosephosphates; Glycosylation; In Vitro Techniques; Indazoles; Protein Binding; Pyrazoles

1988